ArticlePharmacoEconomics2018
Cost Effectiveness of Secukinumab for the Treatment of Active Psoriatic Arthritis in the UK.
Vanessa Buchanan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this paperpooled itcites it